Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes.

Publication ,  Journal Article
Amos, A; Newby, LK
Published in: Curr Cardiol Rep
July 2005

Since the first biomarker of myocardial necrosis was described in 1954, cardiac-specific biomarkers have been increasingly identified. This, coupled with dramatic evolution in assay technology and resultant highly sensitive assays, has rendered a remarkable transformation in the medical use of biomarkers. Initially used to aid in diagnosis of myocardial infarction, newer biomarkers of inflammation, plaque instability, and ischemia may complement biomarkers of necrosis by providing tools to diagnose impending myocardial necrosis before irreversible damage occurs, and offering additional information for risk stratification. Importantly, biomarkers of different processes may be combined to enhance risk stratification above that of any single marker.

Duke Scholars

Published In

Curr Cardiol Rep

DOI

ISSN

1523-3782

Publication Date

July 2005

Volume

7

Issue

4

Start / End Page

263 / 269

Location

United States

Related Subject Headings

  • Troponin
  • Risk Assessment
  • Pregnancy-Associated Plasma Protein-A
  • Peroxidase
  • Necrosis
  • Natriuretic Peptide, Brain
  • Myoglobin
  • Myocardial Ischemia
  • Myocardial Infarction
  • Interleukins
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Amos, A., & Newby, L. K. (2005). Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes. Curr Cardiol Rep, 7(4), 263–269. https://doi.org/10.1007/s11886-005-0047-x
Amos, Ankie, and L Kristin Newby. “Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes.Curr Cardiol Rep 7, no. 4 (July 2005): 263–69. https://doi.org/10.1007/s11886-005-0047-x.
Amos, Ankie, and L. Kristin Newby. “Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes.Curr Cardiol Rep, vol. 7, no. 4, July 2005, pp. 263–69. Pubmed, doi:10.1007/s11886-005-0047-x.
Journal cover image

Published In

Curr Cardiol Rep

DOI

ISSN

1523-3782

Publication Date

July 2005

Volume

7

Issue

4

Start / End Page

263 / 269

Location

United States

Related Subject Headings

  • Troponin
  • Risk Assessment
  • Pregnancy-Associated Plasma Protein-A
  • Peroxidase
  • Necrosis
  • Natriuretic Peptide, Brain
  • Myoglobin
  • Myocardial Ischemia
  • Myocardial Infarction
  • Interleukins